An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins: N- and C-terminal fusion of GFP to the L1 and L2 capsid proteins
Journal Article
2008
Permanent link to this Item
Authors
Journal Title
Archives of Virology
Link to Journal
Journal ISSN
Volume Title
Publisher
Springer Verlag (Germany)
Publisher
University of Cape Town
License
Series
Abstract
Development of vaccine strategies against human papillomavirus (HPV), which causes cervical cancer, is a priority. We investigated the use of virus-like particles (VLPs) of the most prevalent type, HPV-16, as carriers of foreign proteins. Green fluorescent protein (GFP) was fused to the N or C terminus of both L1 and L2, with L2 chimeras being co-expressed with native L1. Purified chimaeric VLPs were comparable in size (*55 nm) to native HPV VLPs. Conformation-specific monoclonal antibodies (Mabs) bound to the VLPs, thereby indicating that they possibly retain their antigenicity. In addition, all of the VLPs encapsidated DNA in the range of 6–8 kb.
Description
Reference:
Windram, O. P., Weber, B., Jaffer, M. A., Rybicki, E. P., Shepherd, D. N., & Varsani, A. (2008). An investigation into the use of human papillomavirus type 16 virus-like particles as a delivery vector system for foreign proteins: N-and C-terminal fusion of GFP to the L1 and L2 capsid proteins. Archives of virology, 153(3), 585-589.